secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZEVRA THERAPEUTICS, INC. (ZVRA)
CIK:        0001434647
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001437749-24-022668
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zevra Therapeutics enters $75M at-the-market equity distribution agreement with Citizens JMP Securities
--------------------------------------------------------------------------------

- ATM facility allows sale of up to $75M in common stock at company's discretion.
- Sales agent receives 3% commission on gross proceeds; shares sold under existing shelf registration.
- Prior equity distribution agreement with Citizens JMP and RBC Capital terminated effective July 12, 2024.
- Company is not obligated to make any sales under the new agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/0001437749-24-022668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/zvra20240711_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer